Optimal Constructing Measures of Novel Research and Development Institutions in Life Sciences and Medicine in China

Zhimin Hu; Xiaofeng Jia; Juntao Yang; Jianwei Qi; Sha Hao; Xiaojuan Xue; Tao Cheng; Boli Zhang; Depei Liu

doi:10.15302/J-SSCAE-2023.05.006

PDF(580 KB)

Strategic Study of CAE ›› 2023, Vol. 25 ›› Issue (5) : 64-71. DOI: 10.15302/J-SSCAE-2023.05.006

Research on technological innovation and development of pharmaceutical and health industry

Orginal Article

Optimal Constructing Measures of Novel Research and Development Institutions in Life Sciences and Medicine in China

Zhimin Hu¹ ,
Xiaofeng Jia² ,
Juntao Yang³^,⁴^,⁵ ,
Jianwei Qi⁵^,⁶^,⁷^,⁸ ,
Sha Hao⁵^,⁶^,⁷^,⁸ ,
Xiaojuan Xue⁹^,¹⁰ ,
Tao Cheng⁵^,⁶^,⁷^,⁸ ,
Boli Zhang⁹^,¹⁰ ,
Depei Liu³^,⁴^,⁵

Author information +

^1.School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730, China;

^2.China National Health Development Research Center, Beijing 100044, China;

^3.Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences & School of Basic Medicine of the Peking Union Medical College,Beijing 100005, China;

^4.State Key Laboratory of Common Mechanism Research for Major Diseases, Beijing 100005, China;

^5.Haihe Laboratory of Cell Ecosystem, Tianjin 300462, China;

^6.Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China;

^7.National Key Laboratory of Blood Science, Tianjin 300020, China;

^8.National Clinical Research Center for Blood Diseases, Tianjin 300020, China;

^9.Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;

10. Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China

Corresponding author: Cheng Tao: chengtao@ihcams.ac.cn; Zhang Boli: zhangbolipr@163.com; Liu Depei: liudp@pumc.edu.cn

Liu Depei is a professor from the Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences & School of Basic Medicine of the Peking Union Medical College, and amember of Chinese Academy of Engineering. His major research fields include medical science and technology policy, biochemistry and molecular biology; Zhang Boli is a professor from the Tianjin University of Traditional Chinese Medicine, and a member of Chinese Academy of Engineering. His major research fields include traditional Chinese medicine strategy, prevention and treatment of cardiovascular and cerebrovascular diseases; Cheng Tao is a professor from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College. His major research field is stem cell biology

Show less

History +

Abstract

Novel research and development (R&D) institutions are an important organizational form of scientific and technological innovation in China. Novel R&D institutions in life sciences and medicine are oriented toward people’s life and health and play an important role in promoting the development of life sciences and medicine, forming multiple innovation subjects, and building an innovation ecology with active elements. However, their construction is still in an exploration stage, and it is urgent to optimize the construction strategy and form a stable and sustainable development capability. This study used the methods of policy research, on-site research, case study, and expert consultation to summarize the progress of policy promotion and exploration practices of novel R&D institutions in China, analyzed the construction modes and operation mechanisms of similar R&D institutions abroad, and presented challenges in the development of novel R&D institutions in the field of life sciences and medicine in China. On this basis, we proposed the following strategies for optimizing the construction of novel R&D institutions in life sciences and medicine in China: (1) building up a diversified and stable funding mechanism, (2) establishing a differentiated development path, (3) improving the recruiting and cultivating mechanism of outstanding professionals, (4) continuously innovating the organizational form of scientific research, (5) exploiting the advantages of the flexible mechanism for scientific achievement transformation, and (6) enhancing the academic influence of these institutions, thereby promoting the high-quality development of these institutions and the self-reliance and strength of China in science and technology.

Keywords

life science / medicine / novel R&D institutions / construction strategy / scientific and technological innovation

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Zhimin Hu, Xiaofeng Jia, Juntao Yang, Jianwei Qi, Sha Hao, Xiaojuan Xue, Tao Cheng, Boli Zhang, Depei Liu. Optimal Constructing Measures of Novel Research and Development Institutions in Life Sciences and Medicine in China. Strategic Study of CAE, 2023, 25(5): 64‒71 https://doi.org/10.15302/J-SSCAE-2023.05.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	中华人民共和国科学技术部‍‍ . 关于促进新型研发机构发展的指导意见 [EBOL]‍. 2019-09-12 [ 2023-07-07 ]‍. https: www‍.‍gov‍.cngongbaocontent2020content_5469722‍.‍htm?ivk_sa=1024320u‍ .

[2]	徐艳 , 王丽萍‍ . 长三角新型研发机构发展现状及建议 [J]‍. 华东科技 , 2022 8 : 41 – 45 ‍.

[3]	科技部火炬中心‍ . 2022年新型研发机构发展报告 [M]‍. 北京 : 科学技术文献出版社 , 2023 ‍.

[4]	湖北省科学技术厅‍ . 湖北省新型研发机构达452家居全国前列 [EBOL]‍. 2023-06-15 ‍[ 2023-07-10 ]‍. https: www‍.‍most‍.‍gov‍.‍cndfkjhubzxdt202306t20230615_186611‍.html‍ .

[5]	中国生物技术发展中心‍ . 2022中国生物医药产业园区竞争力评价及分析报告 [R]‍. 北京 : 中国生物技术发展中心 , 2023 ‍.

[6]	韩凤芹 , 陈亚平‍ . 财政支持新型研发机构的探讨——困境、借鉴与改革路径 [J]‍. 中国高校科技 , 2023 4 : 33 – 40 ‍.

[7]	杨凌春 , 张琰‍ . 从美国Broad Institute看"协同创新" [J]‍. 研究与发展管理 , 2014 , 26 6 : 122 – 128 ‍.

[8]	Institute‍ Broad. David R Liu, Ph‍.D‍. [EB/OL]‍. [2023-07-20]‍. https: //www‍.broadinstitute‍.org/bios/david-liu‍.

[9]	SALK‍. Awards and accolades [EB/OL]‍. [2023-07-20]‍. https: //www‍.salk‍.edu/about/awards-and-accolades/‍.

[10]	Institute‍ McGovern. McGovern institute director receives highest honor from the society for neuroscience [EB/OL]‍. [2023-07-20]‍. https: //mcgovern‍.mit‍.edu/2021/11/08/mcgovern-institute-director-receives-highest-honor-from-the-society-for-neuroscience/‍.

[11]	陈少毅 , 吴红斌‍ . 创新驱动战略下新型研发机构发展的问题及对策 [J]‍. 宏观经济管理 , 2018 6 : 43 – 49 ‍.

Funding

Chinese Academy of Engineering project “Research on the Mechanisms and Systems for Developing First-Class Novel Research and Development Institutions in Life Sciences and Medicine in the New Era” (2022-DFZD-05)